Condition: Turner Syndrome · Hypogonadism; Ovarian · Hormone Replacement Therapy · Sponsor: Aarhus University Hospital
This 5-week, phase IV randomized crossover trial aims to compare the effects of oral versus transdermal estrogen replacement therapy (ERT) in women with Turner syndrome (TS). The objective is to establish the equipotency between the two estradiol regimens by evaluating various estradiol-dependent surrogate markers. The study involves 50 women with TS, aged 18-50 years, who are randomized to receive either oral or transdermal ERT for 14 days, followed by a crossover to the alternate treatment for another 14 days, with a one-week washout period in between. Blood tests are conducted at baseline, after the first 14 days of treatment, after the washout period, and after the final 14 days of treatment. The investigators anticipate that this study will provide clinicians with a better understanding of ERT in treating women with TS.
This description comes directly from the study's public registry record.
Camilla M Balle, Ph.d.-student · 40769623 · camibl@clin.au.dk
Claus H Gravholt, Professor · 78455470 · claus.gravholt@clin.au.dk
Always discuss trial participation with your own doctor first.
| Department of Endocrinology and Internal Medicine, Aarhus University Hospital | Aarhus, Aarhus N, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06544473